Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-18-035180

EVP & Chief Commercial Officer gave up 294 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Dallas Jayson Donald Alexander · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-06-01 Shares withheld for taxes : show line 1 in the form −294 $73.73 $21,677 23,830 D
Loading xslF345X03/doc4.xml…